Sias will work with all suitors to support Hyflux perp holders
THE Securities Investors Association (Singapore), or Sias, said that it is ready to work with all investors to support Hyflux preference shares and perpetual securities (P&P) holders, after a new rescue offer for the beleaguered water treatment company.
American fund manager Strategic Growth Investments (SGI) - Hyflux's fourth and most recent suitor - has proposed to buy and privatise Hyflux with an investment of some S$208 million in cash.
Said Sias president and chief executive David Gerald in a media statement: "Although the SGI term sheet is non-binding and conditional, it contains a proposal to resolve the debts due to all stakeholder groups, including the P&P holders.
"Sias' position is that it is prepared to work with any and all investors to help provide information to the P&P holders and facilitate a restructuring once a binding and unconditional offer is made in such time that the court may allow."
Under a detailed term sheet issued by SGI last week, P&P holders will get S$41.3 million in cash and a share of new convertible securities in Hyflux. Mr Gerald noted in his statement that the cash payout marks a 4 per cent recovery for the P&P holders.
While SGI will not go ahead with its offer if Hyflux moves into judicial management, Hyflux has backed the restructuring offer, dubbing SGI a "preferred investor" and touting the "single-payment cash recovery ... and participation in the company's future growth".
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
On top of several tranches of outstanding notes, Hyflux also owes some S$900 million to about 34,000 P&P retail investors - a longstanding sticking point in restructuring talks.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Air China to buy 100 locally made C919 jets in US$11 billion deal
HCA beats first-quarter profit estimates on higher patient admissions
F&B operator YKGI to exclusively operate Chicha San Chen in Macau for next eight years
LMIRT Q1 net property income dips 3.1% to S$30 million on higher expenses
Exxon misses on Q1 profit despite big gains in Guyana
US FDA approves Pfizer’s gene therapy for rare bleeding disorder